Quorips, a Tokyo venture aiming to commercialize allogenic iPS cell derived cardiomyocyte sheets, obtained about 1 billion yen venture capital from Daiichi Sankyo, Terumo, and Kyoto University Innovation Capital.

Terumo press release, July 11, 2018